Randomized Trial of a Quality Improvement Intervention to Decrease D2B Time in Primary PCI for AMI (RAPID-PCI)
The primary objective of this study is to assess whether an aggressive quality improvement intervention strategy will decrease time from hospital presentation to first balloon inflation in non-transfer patients with acute ST segment elevation MI (STEMI) treated with primary percutaneous coronary intervention (PCI). Twelve hospitals in Michigan were randomized to either aggressive intervention or control. The intervention consisted of Grand Rounds at each hospital, sharing of best practices, and coordinating center staff working closely with staff at each intervention hospital to discuss solutions to barriers to rapid treatment for STEMI patients.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Randomized Trial of Aggressive Process of Care Quality Improvement Intervention to Decrease Door to Balloon Time in Primary PCI for Acute Myocardial Infarction|
- Median Door to Balloon Time [ Time Frame: 2003 to 2006 ] [ Designated as safety issue: No ]
- Risk adjusted mortality in STEMI patients in both groups [ Time Frame: 2 years ] [ Designated as safety issue: No ]
|Study Start Date:||September 2003|
|Study Completion Date:||December 2006|
|Primary Completion Date:||February 2006 (Final data collection date for primary outcome measure)|
Hospitals were randomized to an aggressive intervention strategy or to "business as usual". The hospitals randomized to the aggressive intervention strategy underwent the following:
Hospitals randomized to the control group were instructed to conduct "business as usual".
The participating hospitals randomized to the aggressive intervention strategy actively worked to create teams to analyze processes of care for STEMI patients, identify areas needing improvement, and implemented strategies to streamline treatment.
Hospitals randomized to control were instructed to conduct "business as usual".
Please refer to this study by its ClinicalTrials.gov identifier: NCT01625104
|United States, Michigan|
|University of Michigan|
|Ann Arbor, Michigan, United States, 48109|
|Principal Investigator:||Mauro Moscucci, M.D.||University of Michigan|
|Study Director:||Eva M Kline-Rogers, MS, RN||University of Michigan|